Monthly Regulatory Roundup — July 2026

Beijing Nubway's diode laser hair removal machine (QDTM-04) and Skin Air Cooling System (QALF-01) both received Substantially Equivalent determinations under product code GEX. These are Class II devices, meaning they require 510(k) premarket notification but not premarket approval. As an owner, this means: verify the manufacturer holds FDA clearance before purchasing, confirm the device is labeled for your intended use (general or plastic surgery), and ensure your staff training covers the specific parameters and safety protocols for each platform. Keep clearance documentation on file for audits.

Two separate 510(k) clearances flooded the market with LED light therapy options. XPREEN LED Light Therapy Masks (17 model variants from Dongguan Miqiang) and LED Face Mask Pro FAC08NA / LED Chest Mask Pro FAC09NA (Guangdong Newdermo) all cleared under product code OHS. These are Class II devices used for general and plastic surgery applications. Compliance action: if you're adding LED masks to your menu, verify each specific model number on the FDA's PMCN database, confirm the 510(k) clearance letter matches your purchase, and ensure marketing claims align with the cleared indications (do not overstate benefits beyond what FDA approved).

Volnewmer™ (Classys, Inc., product code GEI) and Capenergy C Equipments RF C200 and C400 Drakarian (Capenergy Medical S.L., product code PBX) both received Substantially Equivalent status. Both are Class II devices for general and plastic surgery use. These RF platforms expand your non-invasive tightening and rejuvenation options. Compliance requirement: confirm your staff has completed manufacturer-specific training before operating, maintain detailed treatment logs (device settings, treatment area, patient response), and ensure your informed consent documents reflect the cleared indications and any known risks disclosed in the 510(k) summary.

LUTRONIC GENIUS (Cynosure Lutronic Technology Corporation, product code GEI) received Substantially Equivalent clearance as a Class II device. This fractional platform joins the growing roster of cleared resurfacing tools. Action items: obtain the full 510(k) summary and predicate device information from Cynosure, cross-reference the cleared indications with your treatment protocols, and ensure your facility's infection control and post-operative care procedures align with manufacturer guidance. Document all staff training and competency assessments.

• Verify clearance status: Cross-check each device against the FDA's PMCN database before purchase or use
• Maintain documentation: Keep 510(k) clearance letters, predicate device comparisons, and labeling on file
• Train staff: Ensure all operators complete manufacturer training specific to each cleared model
• Align marketing: Do not claim indications beyond what FDA approved; review all promotional materials
• Update consent forms: Reflect cleared indications, risks, and downtime in patient documents
• Log treatments: Record device settings, treatment parameters, and patient outcomes for compliance audits
• Monitor recalls: Subscribe to FDA MedWatch alerts for any post-market safety issues

July was quiet on the enforcement front. No medical aesthetic devices were recalled, no state licensing boards issued new compliance directives, and the FTC took no action against aesthetic practices. This calm period is an ideal time to audit your own compliance posture: review your device inventory against FDA clearances, update staff training records, and ensure all marketing claims are defensible. Use this window to strengthen your documentation before the next enforcement cycle.